During the past decade, Stern Cardiovascular Foundation Inc conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 30 clinical trials were completed, i.e. on average, 65.2% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 17 clinical trials were completed. i.e. 113.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stern Cardiovascular Foundation Inc" #1 sponsor was "Medtronic Cardiac Rhythm and Heart Failure" with 8 trials, followed by "Abbott Medical Devices" with 6 trials sponsored, "Boston Scientific Corporation" with 5 trials sponsored, "Pfizer" with 4 trials sponsored and "Bayer" with 4 trials sponsored. Other sponsors include 43 different institutions and companies that sponsored additional 47 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stern Cardiovascular Foundation Inc" #1 collaborator was "Duke Clinical Research Institute" with 4 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "The Cleveland Clinic" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Canadian VIGOUR Centre" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Stern Cardiovascular Foundation Inc" are "Heart Failure" (19 trials), "Atrial Fibrillation" (5 trials), "Heart Failure With Preserved Ejection Fraction" (4 trials), "Cardiovascular Disease" (3 trials) and "Congestive Heart Failure" (3 trials). Many other conditions were trialed in "Stern Cardiovascular Foundation Inc" in a lesser frequency.

Most popular intervention types in "Stern Cardiovascular Foundation Inc" are "Drug" (37 trials), "Device" (30 trials), "Other" (17 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Azimilide Dihydrochloride" (2 trials), "Control" (2 trials), "Oral treprostinil" (2 trials) and "Ranolazine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Stern Cardiovascular Foundation Inc" are 73 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Stern Cardiovascular Foundation Inc". undefined are not yet recruiting, 11 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Stern Cardiovascular Foundation Inc, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Stern Cardiovascular Foundation Inc, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 19 trials that are defined as “Not Applicable".